Luiza Brito Dutra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Luiza Brito Dutra has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Alan Greison Ramos Silva Junior
Centro Universitário FIPMoc - UNIFIPMoc
1 shared publication - Aney Martins Evangelista Filho
Universidade Anhembi Morumbi - UAM
1 shared publication - Cacilda Soares de Moura Ramos
Faculdade Estácio de Sá - Sociedade de Ensino Superior Estácio Ribeirão Preto Ltda
1 shared publication - Caio Mário Do Couto Maldonado
Universidade Anhembi Morumbi - UAM
1 shared publication - Gabriella Gamoski Maccare
Universidade Anhembi Morumbi - UAM
1 shared publication - Gilmara Gabrielli Gregory
Universidade de Cuiabá - UNIC
1 shared publication
Latest Publications
- Open Access
- 1 July 2024
- Published by Uniao Atlantica de Pesquisadores in Concilium
- Vol. 24 (13) , 101-114
Hospitalizations due to malignant skin neoplasm in the unified health system: an ecological time-series study
To analyze hospitalizations due to malignant skin neoplasms in the Brazilian Unified Health System. This is a descriptive ecological study of time series, with data from the SUS Hospital Information System, analyzed using Prais-Winsten generalized linear regression. Between 2013 and 2022, 453.714 hospitalizations due to cutaneous malignancy were recorded, 80.4% of which were elective and the average mortality rate was 2.1%. On the other hand, hospitalizations that progressed to cure showed the highest values (22.7 and 69.1 cases/100,000) and an increasing trend. The hospitalization rate in Brazil grew, from 16.2 cases per 100 thousand inhabitants in 2013 to 28.6 per 100 inhabitants in 2022, however, there was a reduction in 2020 and 2021, the period of the Covid-19 pandemic. There was an increase in the coefficient of hospitalizations during the period analyzed, especially in the age group of 80 years, males and Southern Brazil, although a stationary mortality rate is maintained. Thus, it is important to improve public policies that raise awareness among the population about skin cancer, in order to carry out an early diagnosis and treatment, aiming at reducing complications and saving the public system.
- 1 July 2024
- Published by Uniao Atlantica de Pesquisadores in Concilium
- Vol. 24 (13) , 101-114
Open AccessHospitalizations due to malignant skin neoplasm in the unified health system: an ecological time-series study
To analyze hospitalizations due to malignant skin neoplasms in the Brazilian Unified Health System. This is a descriptive ecological study of time series, with data from the SUS Hospital Information System, analyzed using Prais-Winsten generalized linear regression. Between 2013 and 2022, 453.714 hospitalizations due to cutaneous malignancy were recorded, 80.4% of which were elective and the average mortality rate was 2.1%. On the other hand, hospitalizations that progressed to cure showed the highest values (22.7 and 69.1 cases/100,000) and an increasing trend. The hospitalization rate in Brazil grew, from 16.2 cases per 100 thousand inhabitants in 2013 to 28.6 per 100 inhabitants in 2022, however, there was a reduction in 2020 and 2021, the period of the Covid-19 pandemic. There was an increase in the coefficient of hospitalizations during the period analyzed, especially in the age group of 80 years, males and Southern Brazil, although a stationary mortality rate is maintained. Thus, it is important to improve public policies that raise awareness among the population about skin cancer, in order to carry out an early diagnosis and treatment, aiming at reducing complications and saving the public system.
- Open Access
- 1 January 2024
- Published by Brazilian Journal of Implantology and Health Sciences in Brazilian Journal of Implantology and Health Sciences
- Vol. 6 (1) , 2298-2305
Caminhos para o Diagnóstico Precoce: Biomarcadores Neurogenéticos na Doença de Alzheimer.
This paper proposes a literature review on neurogenetic biomarkers in Alzheimer's disease (AD), highlighting their fundamental role in early diagnosis and understanding of the disease's pathogenesis. The analysis covers the identification of specific genetic variants, such as those in the TOMM40 gene, and polymorphisms identified through genome-wide association studies (GWAS). Additionally, the differential expression of genes associated with AD in early stages offers a unique opportunity for more effective therapeutic interventions. Despite advances, challenges such as external validation and genetic variability are crucial. The neurogenetic approach represents progress in understanding the genetic heterogeneity in AD, providing a foundation for future research. The abstract highlights the promising implications of neurogenetic biomarkers and emphasizes the importance of ethical and social awareness. Este trabalho propõe uma revisão de literatura sobre biomarcadores neurogenéticos na doença de Alzheimer (DA), destacando seu papel fundamental no diagnóstico precoce e na compreensão da patogênese da doença. A análise abrange a identificação de variantes genéticas específicas, como aquelas no gene TOMM40, e polimorfismos identificados por meio de estudos de associação genômica ampla (GWAS). Além disso, a expressão diferencial de genes associados à DA em estágios iniciais oferece uma oportunidade única para intervenções terapêuticas mais eficazes. Apesar dos avanços, desafios como a validação externa e a variabilidade genética são cruciais. A abordagem neurogenética representa um avanço na compreensão da heterogeneidade genética na DA, fornecendo uma base para pesquisas futuras. O resumo destaca as implicações promissoras dos biomarcadores neurogenéticos e destaca a importância da conscientização ética e social.
- 1 January 2024
- Published by Brazilian Journal of Implantology and Health Sciences in Brazilian Journal of Implantology and Health Sciences
- Vol. 6 (1) , 2298-2305
Open AccessCaminhos para o Diagnóstico Precoce: Biomarcadores Neurogenéticos na Doença de Alzheimer.
This paper proposes a literature review on neurogenetic biomarkers in Alzheimer's disease (AD), highlighting their fundamental role in early diagnosis and understanding of the disease's pathogenesis. The analysis covers the identification of specific genetic variants, such as those in the TOMM40 gene, and polymorphisms identified through genome-wide association studies (GWAS). Additionally, the differential expression of genes associated with AD in early stages offers a unique opportunity for more effective therapeutic interventions. Despite advances, challenges such as external validation and genetic variability are crucial. The neurogenetic approach represents progress in understanding the genetic heterogeneity in AD, providing a foundation for future research. The abstract highlights the promising implications of neurogenetic biomarkers and emphasizes the importance of ethical and social awareness. Este trabalho propõe uma revisão de literatura sobre biomarcadores neurogenéticos na doença de Alzheimer (DA), destacando seu papel fundamental no diagnóstico precoce e na compreensão da patogênese da doença. A análise abrange a identificação de variantes genéticas específicas, como aquelas no gene TOMM40, e polimorfismos identificados por meio de estudos de associação genômica ampla (GWAS). Além disso, a expressão diferencial de genes associados à DA em estágios iniciais oferece uma oportunidade única para intervenções terapêuticas mais eficazes. Apesar dos avanços, desafios como a validação externa e a variabilidade genética são cruciais. A abordagem neurogenética representa um avanço na compreensão da heterogeneidade genética na DA, fornecendo uma base para pesquisas futuras. O resumo destaca as implicações promissoras dos biomarcadores neurogenéticos e destaca a importância da conscientização ética e social.